Evonik Industries (FRA:EVK) has been assigned a €39.00 ($46.43) target price by investment analysts at Societe Generale in a report released on Thursday. The brokerage presently has a “buy” rating on the stock. Societe Generale’s target price indicates a potential upside of 24.12% from the stock’s current price.
Several other equities research analysts have also weighed in on EVK. Barclays set a €34.50 ($41.07) target price on Evonik Industries and gave the stock a “buy” rating in a research report on Friday, September 29th. UBS Group set a €27.00 ($32.14) target price on Evonik Industries and gave the stock a “sell” rating in a research report on Monday, January 8th. Deutsche Bank set a €32.00 ($38.10) target price on Evonik Industries and gave the stock a “neutral” rating in a research report on Thursday, September 28th. Credit Suisse Group set a €34.30 ($40.83) price target on Evonik Industries and gave the stock a “buy” rating in a research note on Tuesday, September 26th. Finally, Warburg Research set a €38.70 ($46.07) price target on Evonik Industries and gave the stock a “buy” rating in a research note on Wednesday. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of €33.87 ($40.32).
Shares of Evonik Industries (FRA EVK) traded up €0.39 ($0.46) during midday trading on Thursday, reaching €31.42 ($37.40). The company’s stock had a trading volume of 537,379 shares. Evonik Industries has a 1 year low of €26.78 ($31.88) and a 1 year high of €32.97 ($39.25). The firm has a market capitalization of $14,630.00 and a price-to-earnings ratio of 20.01.
TRADEMARK VIOLATION NOTICE: This report was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/01/13/evonik-industries-evk-pt-set-at-39-00-by-societe-generale.html.
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.